G Foussias

Summary

Affiliation: Centre for Addiction and Mental Health
Country: Canada

Publications

  1. pmc Negative symptoms in schizophrenia: avolition and Occam's razor
    George Foussias
    Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Schizophr Bull 36:359-69. 2010
  2. doi request reprint Motivational deficits as the central link to functioning in schizophrenia: a pilot study
    G Foussias
    Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Schizophr Res 115:333-7. 2009
  3. ncbi request reprint Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making
    George Foussias
    Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario
    Can J Psychiatry 55:117-25. 2010
  4. doi request reprint Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits
    G Foussias
    Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, 250 College St, Toronto, Ontario, Canada M5T 1R8
    Schizophr Res 132:24-7. 2011
  5. doi request reprint Progress in defining optimal treatment outcome in schizophrenia
    Gary Remington
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    CNS Drugs 24:9-20. 2010
  6. doi request reprint Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
    Ofer Agid
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Expert Opin Pharmacother 11:2301-17. 2010
  7. ncbi request reprint Where to position clozapine: re-examining the evidence
    Ofer Agid
    Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 55:677-84. 2010

Detail Information

Publications7

  1. pmc Negative symptoms in schizophrenia: avolition and Occam's razor
    George Foussias
    Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Schizophr Bull 36:359-69. 2010
    ..Further exploration and clarification of this core deficit will ultimately enhance our neurobiological understanding of schizophrenia, as well as strategies that may improve outcome...
  2. doi request reprint Motivational deficits as the central link to functioning in schizophrenia: a pilot study
    G Foussias
    Department of Psychiatry, University of Toronto, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Schizophr Res 115:333-7. 2009
    ..This suggests that motivational deficits are the central link between negative symptoms and functional impairment in schizophrenia...
  3. ncbi request reprint Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making
    George Foussias
    Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario
    Can J Psychiatry 55:117-25. 2010
    ....
  4. doi request reprint Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits
    G Foussias
    Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, 250 College St, Toronto, Ontario, Canada M5T 1R8
    Schizophr Res 132:24-7. 2011
    ..These findings further suggest a fundamental role for motivational deficits in predicting functional outcomes in schizophrenia...
  5. doi request reprint Progress in defining optimal treatment outcome in schizophrenia
    Gary Remington
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    CNS Drugs 24:9-20. 2010
    ..To this end, the field has now embraced a recovery model that is seen as a process, multidimensional and individualized, rather than dichotomous and symptom driven...
  6. doi request reprint Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
    Ofer Agid
    Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Expert Opin Pharmacother 11:2301-17. 2010
    ..However, nonadherence with antipsychotic treatment is a significant issue, with estimates as high as 90%...
  7. ncbi request reprint Where to position clozapine: re-examining the evidence
    Ofer Agid
    Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario
    Can J Psychiatry 55:677-84. 2010
    ..To review clozapine's position in treatment algorithms for schizophrenia...